LC
Lindbrook Capital Portfolio holdings
AUM
$1.08B
1-Year Return
10.14%
This Quarter Return
-2.38%
1 Year Return
+10.14%
3 Year Return
+35.76%
5 Year Return
+141%
10 Year Return
–
AUM
$894M
AUM Growth
-$45.6M
(-4.8%)
Cap. Flow
-$15.5M
Cap. Flow
% of AUM
-1.74%
Top 10 Holdings %
Top 10 Hldgs %
46.04%
Holding
2,910
New
179
Increased
1,151
Reduced
725
Closed
200
Top Buys
| 1 |
Vanguard Total Stock Market ETF
VTI
|
+$1.04M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.01M |
| 3 |
Vanguard Value ETF
VTV
|
+$961K |
| 4 |
Oneok
OKE
|
+$852K |
| 5 |
Kinder Morgan
KMI
|
+$756K |
Top Sells
| 1 |
Oaktree Specialty Lending
OCSL
|
+$7.45M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$1.86M |
| 3 |
SPDR S&P 500 ETF Trust
SPY
|
+$1.56M |
| 4 |
NVIDIA
NVDA
|
+$1.47M |
| 5 |
NovoCure
NVCR
|
+$1.24M |
Sector Composition
| 1 | Financials | 16.87% |
| 2 | Technology | 14.74% |
| 3 | Healthcare | 5.91% |
| 4 | Consumer Discretionary | 3.51% |
| 5 | Industrials | 3.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Couchbase
BASE
$1.35B
| $2.15K | ﹤0.01% |
125
| – | – |
|
2102
Dine Brands
DIN
$368M
| $2.13K | ﹤0.01% |
+43
| New | +$2.13K |
|
2103
American States Water
AWR
$2.82B
| $2.12K | ﹤0.01% |
27
-73
| -73% | -$5.74K |
|
2104
Texas Capital Bancshares
TCBI
$3.98B
| $2.12K | ﹤0.01% |
36
+15
| +71% | +$883 |
|
2105
Amneal Pharmaceuticals
AMRX
$3.14B
| $2.12K | ﹤0.01% |
502
| – | – |
|
2106
Navient
NAVI
$1.28B
| $2.12K | ﹤0.01% |
123
+11
| +10% | +$189 |
|
2107
ONE Gas
OGS
$4.55B
| $2.12K | ﹤0.01% |
31
-192
| -86% | -$13.1K |
|
2108
Blue Owl Capital
OWL
$12.2B
| $2.11K | ﹤0.01% |
163
+45
| +38% | +$583 |
|
2109
Immunovant
IMVT
$2.82B
| $2.11K | ﹤0.01% |
55
+34
| +162% | +$1.31K |
|
2110
Veracyte
VCYT
$2.43B
| $2.1K | ﹤0.01% |
94
-28
| -23% | -$625 |
|
2111
Cardlytics
CDLX
$59.6M
| $2.1K | ﹤0.01% |
+127
| New | +$2.1K |
|
2112
Century Communities
CCS
$2B
| $2.07K | ﹤0.01% |
31
| – | – |
|
2113
Lineage Cell Therapeutics
LCTX
$306M
| $2.07K | ﹤0.01% |
1,754
| – | – |
|
2114
Erasca
ERAS
$443M
| $2.07K | ﹤0.01% |
1,049
-306
| -23% | -$603 |
|
2115
Bloomin' Brands
BLMN
$577M
| $2.07K | ﹤0.01% |
84
-11
| -12% | -$271 |
|
2116
York Water
YORW
$445M
| $2.06K | ﹤0.01% |
55
-27
| -33% | -$1.01K |
|
2117
Cross Country Healthcare
CCRN
$411M
| $2.06K | ﹤0.01% |
83
| – | – |
|
2118
Allogene Therapeutics
ALLO
$251M
| $2.05K | ﹤0.01% |
648
-725
| -53% | -$2.3K |
|
2119
Informatica
INFA
$7.55B
| $2.04K | ﹤0.01% |
97
| – | – |
|
|
TBI
2120
Trueblue
TBI
$179M
| $2.04K | ﹤0.01% |
139
+119
| +595% | +$1.75K |
|
2121
GlobalFoundries
GFS
$17.6B
| $2.04K | ﹤0.01% |
35
+2
| +6% | +$116 |
|
|
STER
2122
DELISTED
Sterling Check Corp. Common Stock
STER
| $2.03K | ﹤0.01% |
161
+9
| +6% | +$114 |
|
2123
Frontline
FRO
$5.17B
| $2.03K | ﹤0.01% |
108
| – | – |
|
2124
Newegg Commerce
NEGG
$901M
| $2.02K | ﹤0.01% |
120
+43
| +56% | +$725 |
|
2125
Virtus Investment Partners
VRTS
$1.34B
| $2.02K | ﹤0.01% |
10
-3
| -23% | -$606 |
|